Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00334932
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2006-06-07
Brief Title:
Doxorubicin Hydrochloride Liposome Melphalan and Bortezomib in Treating Patients With Relapsed or Refractory Stage I Stage II or Stage III Multiple Myeloma
Sponsor:
Herbert Irving Comprehensive Cancer Center
Organization:
National Cancer Institute NCI